BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biologics

Eleva and 3PBIOVIAN Forge Strategic Alliance to Advance Clinical-Grade Biologics Production

3PBIOVIAN provides production capacity for clinical-grade material for current and future development programs including Eleva’s proprietary Factor...

February 05, 2025 | News

Helix Introduces Clinico-Genomic Dataset of 15,000 GLP-1 Agonist Patients to Advance Precision Medicine

Helix, a leader in precision health, is unveiling a new comprehensive clinico-genomic dataset of over 15,000 patients treated with glucagon...

February 04, 2025 | News

Nona Biosciences and Invetx Forge Strategic Alliance to Advance Next-Gen Animal Health Biotherapeutics

Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), announced that it has entered into a s...

February 04, 2025 | News

Bristol Myers Squibb’s Breyanzi Recommended for EU Approval After 97% Response Rate in Follicular Lymphoma

Recommendation based on the Phase 2 TRANSCEND FL study in which 97.1% of patients responded to Breyanzi, with 94.2% of patients achieving comple...

February 03, 2025 | News

Daiichi Sankyo & AstraZeneca’s Datopotamab Deruxtecan Recommended for EU Approval After Cutting Disease Progression Risk by 37%

Recommendation based on TROPION-Breast01 results showing Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan reduced risk of disease prog...

February 03, 2025 | News

China Approves Sarclisa as First Anti-CD38 Therapy for Newly Diagnosed Multiple Myeloma Patients

Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant A...

January 31, 2025 | News

Telix Pharmaceuticals Completes Acquisition of ImaginAb’s Next-Gen Therapeutic Pipeline and Biologics Platform

Telix Pharmaceuticals Limited announces it has completed the acquisition from antibody engineering company ImaginAb, Inc. (ImaginAb). The acquisition inclu...

January 31, 2025 | News

CPC Introduces MicroCNX® Nano Series Connectors to Streamline Cell and Gene Therapy Processing

CPC (Colder Products Company), part of Dover (NYSE: DOV) and a leading manufacturer of connection technologies used in biopharmaceutic...

January 30, 2025 | News

C2 PHARMA Secures CEP Approval for Oxybuprocaine Hydrochloride, Expanding Global Market Access

C2 PHARMA, the global leader in manufacturing and supplying ophthalmic and niche active pharmaceutical ingredients (APIs), proudly announces the appro...

January 29, 2025 | News

Genialis Extends Collaboration with Debiopharm to Advance RNA-Based Biomarker for WEE1-Targeted Therapy

Genialis, the RNA biomarker company, announced an extension of its collaboration with Debiopharm, a Swiss-based global biopharmaceutical company, to develo...

January 29, 2025 | News

Mayo Clinic Laboratories and Lucence Join Forces to Enhance Cancer Diagnostics Across U.S. and Asia

Mayo Clinic Laboratories, a global leader in advanced laboratory testing, and Lucence, a pioneering molecular diagnostics company, announced a strategic co...

January 27, 2025 | News

Samsung Biologics Eyes Growth in 2025 with New Plant, ADC Services, and Sustainability Investments

Recorded Q4'24 consolidated revenue of KRW 1.26 trillion Recorded FY'24 consolidated revenue of KRW 4.55 trillion Poised for further growth w...

January 23, 2025 | News

CARsgen Therapeutics Administers First Dose of KJ-C2320 Allogeneic CAR T-Cell Therapy in Investigator-Initiated Trial

CARsgen Therapeutics Holdings Limited , a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors...

January 21, 2025 | News

IMPACT Therapeutics’ Senaparib Gains NMPA Approval as First-Line Maintenance Therapy for Advanced Ovarian Cancer

IMPACT Therapeutics ("IMPACT"), a biopharmaceutical company focusing on the discovery and development of targeted anti-cancer therapeutics based on synthet...

January 17, 2025 | News

Stay Connected